Global Diabetes Management Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Diabetes Management market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Diabetes Management market size is estimated to be worth US$ 5524.5 million in 2021 and is forecast to a readjusted size of USD 12930 million by 2028 with a CAGR of 12.9% during review period. Hospital accounting for % of the Diabetes Management global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monitoring Devices segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Diabetes Management include Ascensia Diabetes Care, Abbott Laboratories, Medtronic, Roche, and Dexcom, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Diabetes Management market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monitoring Devices
Diagnostic Devices
Insulin Delivery Devices
Other Devices
Market segment by Application, can be divided into
Hospital
Clinic
Home Care
Market segment by players, this report covers
Ascensia Diabetes Care
Abbott Laboratories
Medtronic
Roche
Dexcom
Insulet Corporation
Tandem Diabetes Care
LifeScan
AgaMatrix
Animas
ARKRAY
BD
Beta Bionics.
Eli Lilly
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Diabetes Management product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Diabetes Management, with revenue, gross margin and global market share of Diabetes Management from 2019 to 2022.
Chapter 3, the Diabetes Management competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Diabetes Management market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Diabetes Management research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Diabetes Management
1.2 Classification of Diabetes Management by Type
1.2.1 Overview: Global Diabetes Management Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Diabetes Management Revenue Market Share by Type in 2021
1.2.3 Monitoring Devices
1.2.4 Diagnostic Devices
1.2.5 Insulin Delivery Devices
1.2.6 Other Devices
1.3 Global Diabetes Management Market by Application
1.3.1 Overview: Global Diabetes Management Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.4 Global Diabetes Management Market Size & Forecast
1.5 Global Diabetes Management Market Size and Forecast by Region
1.5.1 Global Diabetes Management Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Diabetes Management Market Size by Region, (2017-2022)
1.5.3 North America Diabetes Management Market Size and Prospect (2017-2028)
1.5.4 Europe Diabetes Management Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Diabetes Management Market Size and Prospect (2017-2028)
1.5.6 South America Diabetes Management Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Diabetes Management Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Diabetes Management Market Drivers
1.6.2 Diabetes Management Market Restraints
1.6.3 Diabetes Management Trends Analysis
2 Company Profiles
2.1 Ascensia Diabetes Care
2.1.1 Ascensia Diabetes Care Details
2.1.2 Ascensia Diabetes Care Major Business
2.1.3 Ascensia Diabetes Care Diabetes Management Product and Solutions
2.1.4 Ascensia Diabetes Care Diabetes Management Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Ascensia Diabetes Care Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Diabetes Management Product and Solutions
2.2.4 Abbott Laboratories Diabetes Management Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Diabetes Management Product and Solutions
2.3.4 Medtronic Diabetes Management Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Medtronic Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Diabetes Management Product and Solutions
2.4.4 Roche Diabetes Management Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Roche Recent Developments and Future Plans
2.5 Dexcom
2.5.1 Dexcom Details
2.5.2 Dexcom Major Business
2.5.3 Dexcom Diabetes Management Product and Solutions
2.5.4 Dexcom Diabetes Management Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Dexcom Recent Developments and Future Plans
2.6 Insulet Corporation
2.6.1 Insulet Corporation Details
2.6.2 Insulet Corporation Major Business
2.6.3 Insulet Corporation Diabetes Management Product and Solutions
2.6.4 Insulet Corporation Diabetes Management Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Insulet Corporation Recent Developments and Future Plans
2.7 Tandem Diabetes Care
2.7.1 Tandem Diabetes Care Details
2.7.2 Tandem Diabetes Care Major Business
2.7.3 Tandem Diabetes Care Diabetes Management Product and Solutions
2.7.4 Tandem Diabetes Care Diabetes Management Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Tandem Diabetes Care Recent Developments and Future Plans
2.8 LifeScan
2.8.1 LifeScan Details
2.8.2 LifeScan Major Business
2.8.3 LifeScan Diabetes Management Product and Solutions
2.8.4 LifeScan Diabetes Management Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 LifeScan Recent Developments and Future Plans
2.9 AgaMatrix
2.9.1 AgaMatrix Details
2.9.2 AgaMatrix Major Business
2.9.3 AgaMatrix Diabetes Management Product and Solutions
2.9.4 AgaMatrix Diabetes Management Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 AgaMatrix Recent Developments and Future Plans
2.10 Animas
2.10.1 Animas Details
2.10.2 Animas Major Business
2.10.3 Animas Diabetes Management Product and Solutions
2.10.4 Animas Diabetes Management Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Animas Recent Developments and Future Plans
2.11 ARKRAY
2.11.1 ARKRAY Details
2.11.2 ARKRAY Major Business
2.11.3 ARKRAY Diabetes Management Product and Solutions
2.11.4 ARKRAY Diabetes Management Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 ARKRAY Recent Developments and Future Plans
2.12 BD
2.12.1 BD Details
2.12.2 BD Major Business
2.12.3 BD Diabetes Management Product and Solutions
2.12.4 BD Diabetes Management Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 BD Recent Developments and Future Plans
2.13 Beta Bionics.
2.13.1 Beta Bionics. Details
2.13.2 Beta Bionics. Major Business
2.13.3 Beta Bionics. Diabetes Management Product and Solutions
2.13.4 Beta Bionics. Diabetes Management Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Beta Bionics. Recent Developments and Future Plans
2.14 Eli Lilly
2.14.1 Eli Lilly Details
2.14.2 Eli Lilly Major Business
2.14.3 Eli Lilly Diabetes Management Product and Solutions
2.14.4 Eli Lilly Diabetes Management Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Eli Lilly Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Diabetes Management Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Diabetes Management Players Market Share in 2021
3.2.2 Top 10 Diabetes Management Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Diabetes Management Players Head Office, Products and Services Provided
3.4 Diabetes Management Mergers & Acquisitions
3.5 Diabetes Management New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Diabetes Management Revenue and Market Share by Type (2017-2022)
4.2 Global Diabetes Management Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Diabetes Management Revenue Market Share by Application (2017-2022)
5.2 Global Diabetes Management Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Diabetes Management Revenue by Type (2017-2028)
6.2 North America Diabetes Management Revenue by Application (2017-2028)
6.3 North America Diabetes Management Market Size by Country
6.3.1 North America Diabetes Management Revenue by Country (2017-2028)
6.3.2 United States Diabetes Management Market Size and Forecast (2017-2028)
6.3.3 Canada Diabetes Management Market Size and Forecast (2017-2028)
6.3.4 Mexico Diabetes Management Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Diabetes Management Revenue by Type (2017-2028)
7.2 Europe Diabetes Management Revenue by Application (2017-2028)
7.3 Europe Diabetes Management Market Size by Country
7.3.1 Europe Diabetes Management Revenue by Country (2017-2028)
7.3.2 Germany Diabetes Management Market Size and Forecast (2017-2028)
7.3.3 France Diabetes Management Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Diabetes Management Market Size and Forecast (2017-2028)
7.3.5 Russia Diabetes Management Market Size and Forecast (2017-2028)
7.3.6 Italy Diabetes Management Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Diabetes Management Revenue by Type (2017-2028)
8.2 Asia-Pacific Diabetes Management Revenue by Application (2017-2028)
8.3 Asia-Pacific Diabetes Management Market Size by Region
8.3.1 Asia-Pacific Diabetes Management Revenue by Region (2017-2028)
8.3.2 China Diabetes Management Market Size and Forecast (2017-2028)
8.3.3 Japan Diabetes Management Market Size and Forecast (2017-2028)
8.3.4 South Korea Diabetes Management Market Size and Forecast (2017-2028)
8.3.5 India Diabetes Management Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Diabetes Management Market Size and Forecast (2017-2028)
8.3.7 Australia Diabetes Management Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Diabetes Management Revenue by Type (2017-2028)
9.2 South America Diabetes Management Revenue by Application (2017-2028)
9.3 South America Diabetes Management Market Size by Country
9.3.1 South America Diabetes Management Revenue by Country (2017-2028)
9.3.2 Brazil Diabetes Management Market Size and Forecast (2017-2028)
9.3.3 Argentina Diabetes Management Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Diabetes Management Revenue by Type (2017-2028)
10.2 Middle East & Africa Diabetes Management Revenue by Application (2017-2028)
10.3 Middle East & Africa Diabetes Management Market Size by Country
10.3.1 Middle East & Africa Diabetes Management Revenue by Country (2017-2028)
10.3.2 Turkey Diabetes Management Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Diabetes Management Market Size and Forecast (2017-2028)
10.3.4 UAE Diabetes Management Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Diabetes Management Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Diabetes Management Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Diabetes Management Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Diabetes Management Revenue (USD Million) by Region (2017-2022)
Table 5. Global Diabetes Management Revenue Market Share by Region (2023-2028)
Table 6. Ascensia Diabetes Care Corporate Information, Head Office, and Major Competitors
Table 7. Ascensia Diabetes Care Major Business
Table 8. Ascensia Diabetes Care Diabetes Management Product and Solutions
Table 9. Ascensia Diabetes Care Diabetes Management Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories Diabetes Management Product and Solutions
Table 13. Abbott Laboratories Diabetes Management Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Medtronic Corporate Information, Head Office, and Major Competitors
Table 15. Medtronic Major Business
Table 16. Medtronic Diabetes Management Product and Solutions
Table 17. Medtronic Diabetes Management Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Diabetes Management Product and Solutions
Table 21. Roche Diabetes Management Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Dexcom Corporate Information, Head Office, and Major Competitors
Table 23. Dexcom Major Business
Table 24. Dexcom Diabetes Management Product and Solutions
Table 25. Dexcom Diabetes Management Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Insulet Corporation Corporate Information, Head Office, and Major Competitors
Table 27. Insulet Corporation Major Business
Table 28. Insulet Corporation Diabetes Management Product and Solutions
Table 29. Insulet Corporation Diabetes Management Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Tandem Diabetes Care Corporate Information, Head Office, and Major Competitors
Table 31. Tandem Diabetes Care Major Business
Table 32. Tandem Diabetes Care Diabetes Management Product and Solutions
Table 33. Tandem Diabetes Care Diabetes Management Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. LifeScan Corporate Information, Head Office, and Major Competitors
Table 35. LifeScan Major Business
Table 36. LifeScan Diabetes Management Product and Solutions
Table 37. LifeScan Diabetes Management Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. AgaMatrix Corporate Information, Head Office, and Major Competitors
Table 39. AgaMatrix Major Business
Table 40. AgaMatrix Diabetes Management Product and Solutions
Table 41. AgaMatrix Diabetes Management Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Animas Corporate Information, Head Office, and Major Competitors
Table 43. Animas Major Business
Table 44. Animas Diabetes Management Product and Solutions
Table 45. Animas Diabetes Management Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. ARKRAY Corporate Information, Head Office, and Major Competitors
Table 47. ARKRAY Major Business
Table 48. ARKRAY Diabetes Management Product and Solutions
Table 49. ARKRAY Diabetes Management Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. BD Corporate Information, Head Office, and Major Competitors
Table 51. BD Major Business
Table 52. BD Diabetes Management Product and Solutions
Table 53. BD Diabetes Management Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Beta Bionics. Corporate Information, Head Office, and Major Competitors
Table 55. Beta Bionics. Major Business
Table 56. Beta Bionics. Diabetes Management Product and Solutions
Table 57. Beta Bionics. Diabetes Management Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 59. Eli Lilly Major Business
Table 60. Eli Lilly Diabetes Management Product and Solutions
Table 61. Eli Lilly Diabetes Management Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Diabetes Management Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Diabetes Management Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Diabetes Management by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Diabetes Management Players Head Office, Products and Services Provided
Table 66. Diabetes Management Mergers & Acquisitions in the Past Five Years
Table 67. Diabetes Management New Entrants and Expansion Plans
Table 68. Global Diabetes Management Revenue (USD Million) by Type (2017-2022)
Table 69. Global Diabetes Management Revenue Share by Type (2017-2022)
Table 70. Global Diabetes Management Revenue Forecast by Type (2023-2028)
Table 71. Global Diabetes Management Revenue by Application (2017-2022)
Table 72. Global Diabetes Management Revenue Forecast by Application (2023-2028)
Table 73. North America Diabetes Management Revenue by Type (2017-2022) & (USD Million)
Table 74. North America Diabetes Management Revenue by Type (2023-2028) & (USD Million)
Table 75. North America Diabetes Management Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Diabetes Management Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Diabetes Management Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Diabetes Management Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Diabetes Management Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe Diabetes Management Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe Diabetes Management Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Diabetes Management Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Diabetes Management Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Diabetes Management Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Diabetes Management Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Diabetes Management Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Diabetes Management Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Diabetes Management Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Diabetes Management Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Diabetes Management Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Diabetes Management Revenue by Type (2017-2022) & (USD Million)
Table 92. South America Diabetes Management Revenue by Type (2023-2028) & (USD Million)
Table 93. South America Diabetes Management Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Diabetes Management Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Diabetes Management Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Diabetes Management Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Diabetes Management Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Diabetes Management Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Diabetes Management Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Diabetes Management Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Diabetes Management Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Diabetes Management Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Diabetes Management Picture
Figure 2. Global Diabetes Management Revenue Market Share by Type in 2021
Figure 3. Monitoring Devices
Figure 4. Diagnostic Devices
Figure 5. Insulin Delivery Devices
Figure 6. Other Devices
Figure 7. Diabetes Management Revenue Market Share by Application in 2021
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Home Care Picture
Figure 11. Global Diabetes Management Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Diabetes Management Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Diabetes Management Revenue Market Share by Region (2017-2028)
Figure 14. Global Diabetes Management Revenue Market Share by Region in 2021
Figure 15. North America Diabetes Management Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Diabetes Management Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Diabetes Management Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Diabetes Management Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Diabetes Management Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Diabetes Management Market Drivers
Figure 21. Diabetes Management Market Restraints
Figure 22. Diabetes Management Market Trends
Figure 23. Ascensia Diabetes Care Recent Developments and Future Plans
Figure 24. Abbott Laboratories Recent Developments and Future Plans
Figure 25. Medtronic Recent Developments and Future Plans
Figure 26. Roche Recent Developments and Future Plans
Figure 27. Dexcom Recent Developments and Future Plans
Figure 28. Insulet Corporation Recent Developments and Future Plans
Figure 29. Tandem Diabetes Care Recent Developments and Future Plans
Figure 30. LifeScan Recent Developments and Future Plans
Figure 31. AgaMatrix Recent Developments and Future Plans
Figure 32. Animas Recent Developments and Future Plans
Figure 33. ARKRAY Recent Developments and Future Plans
Figure 34. BD Recent Developments and Future Plans
Figure 35. Beta Bionics. Recent Developments and Future Plans
Figure 36. Eli Lilly Recent Developments and Future Plans
Figure 37. Global Diabetes Management Revenue Share by Players in 2021
Figure 38. Diabetes Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Diabetes Management Revenue Market Share in 2021
Figure 40. Global Top 10 Players Diabetes Management Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Diabetes Management Revenue Share by Type in 2021
Figure 43. Global Diabetes Management Market Share Forecast by Type (2023-2028)
Figure 44. Global Diabetes Management Revenue Share by Application in 2021
Figure 45. Global Diabetes Management Market Share Forecast by Application (2023-2028)
Figure 46. North America Diabetes Management Sales Market Share by Type (2017-2028)
Figure 47. North America Diabetes Management Sales Market Share by Application (2017-2028)
Figure 48. North America Diabetes Management Revenue Market Share by Country (2017-2028)
Figure 49. United States Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Diabetes Management Sales Market Share by Type (2017-2028)
Figure 53. Europe Diabetes Management Sales Market Share by Application (2017-2028)
Figure 54. Europe Diabetes Management Revenue Market Share by Country (2017-2028)
Figure 55. Germany Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Diabetes Management Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Diabetes Management Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Diabetes Management Revenue Market Share by Region (2017-2028)
Figure 63. China Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Diabetes Management Sales Market Share by Type (2017-2028)
Figure 70. South America Diabetes Management Sales Market Share by Application (2017-2028)
Figure 71. South America Diabetes Management Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Diabetes Management Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Diabetes Management Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Diabetes Management Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Diabetes Management Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
